SME Times is powered by   
Search News
Just in:   • RBI clarifies forex rules for services exports and imports  • Govt encourages industry to boost India's domestic, overseas mineral supply chains  • Trump cites India's growth to press Fed on rates  • FIIs pump Rs 1,11,950 crore into Indian stock markets this month to date  • India poised for big leap in AI, semiconductor manufacturing 
Last updated: 01 Jun, 2017  

Pfizer.9.Thmb.jpg Pfizer buys AstraZeneca's drug for Rs 75 cr

Pfizer.9.jpg
   Top Stories
» FIIs pump Rs 1,11,950 crore into Indian stock markets this month to date
» Sensex jumps 898 points, Nifty closes above 25,800 as banks rally on return of foreign inflows
» Microsoft rolls out agentic AI tools, Copilot Workspaces at Ignite conference
» Nifty hits 9-month high, Bank Nifty scales record peak as market rally extends
» India-Egypt trade has potential to scale $35 billion by 2035: Assocham
SME Times News Bureau | 01 Jun, 2017
American pharma major Pfizer's Indian arm on Wednesday announced that it had acquired the Neksium brand of the Swedish drug MNC AstraZeneca for Rs 75 crore.

"The drug, used for treating peptic ulcers, will support our India strategy to boost its coverage and equity in the gastro-intestinal therapy area," said Pfizer India Ltd in a regulatory filing to the BSE.

Pfizer introduced the drug in India in 2006 and developed equity with its prescribers in the anti-peptic ulcerant space.

"With Esomeprazole ingredient, Neksium belongs to a class of preeparations called 'Proton Pump Inhibitors', which are used for reducing the acid secretion in the stomach," said PFizer in a statementrA

The drug is also prescribed for treating conditions of peptic acid disorders.

"The acquisition is in line with the portfolio expansion through organic and inorganic growth in our focus therapy areas," said Pfizer Managing Director S. Sridhar.

With brands like Gelusil and Mucaine, Pfizer has been a provider for solutions in the antacid space for over 30 years.
 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹96.5
₹94.8
UK Pound
₹132.25
₹128.15
Euro
₹113.6
₹109.8
Japanese Yen ₹61.3 ₹59.45
As on 03 Sep, 2026
  Daily Poll
What’s your biggest challenge with the 45-day payment rule?
 Corporates canceling our orders
 Clients demanding longer credit anyway
 Strained business relationships
 Filing complaints kills future work
 No issues, cash flow has improved
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter